Side-effect rates in the Phase 2 trial varied substantially by dose
Patients should contact their healthcare provider if mucus in stool is accompanied by any of the following warning signs: Immediate medical attention is recommended for: Severe, persistent abdominal pain, especially if radiating to the back or accompanied by nausea/vomiting (possible pancreatitis) Blood in stool (red blood or black, tarry stools) Right upper quadrant pain, especially with fever or yellowing of skin/eyes (possible gallbladder disease) Fever above 100.4F (38C) Signs of dehydration (decreased urination, dizziness, extreme thirst, dry mouth) Unintentional weight loss beyond expected therapeutic effects Persistent vomiting preventing adequate fluid intake Schedule a routine appointment if experiencing: Mucus in stool persisting beyond 1-2 weeks Significant changes in bowel habits (frequency, consistency, or appearance) Mucus accompanied by persistent bloating or discomfort New onset of symptoms after stable medication tolerance Concerns about symptom severity or impact on quality of life Healthcare providers will typically conduct a thorough clinical assessment including detailed history, physical examination, and potentially laboratory investigations
Supports youthful, radiant skin by nourishing from within
Even though there are no studies or clinical trials that show BPC-157 is safe or effective in humans, some websites related to performance-enhancing drugs advertise that it can be injected or taken orally for bone and joint healing, stomach ulcers, organ damage, and a number of other purposes, including athletic performance enhancement
Ready to see the full lineup
Ume6 protein complexes connect morphogenesis, adherence and hypoxic genes to shape Candida albicans biofilm architecture
